glp 1 drug makers Patients' Use GLP-1 Drugs for Weight Loss, Benefit Gains Eli Lilly's $1 Trillion Boom:

GLP-1RAs could potentially skew the human macrophage phenotype toward an anti-inflammatory state by increasing IL-10 and suppressing pro-inflammatory cytokines such as TNF-, IL-1

Bottom Line: People on GLP-1s Should Be Monitored for Health Changes Experts say the findings should not discourage appropriate use of GLP-1 medications, which provide significant benefits for many people with diabetes and obesity, including improvements in heart health, kidney function, and liver disease

Whole transcriptome analysis of the er synthetic fragment p295-t311 (er17p) identifies specific er-isoform (er, er36)-dependent and -independent actions in breast cancer cells

Immunotherapies most commonly, immune checkpoint inhibitors can be extremely effective but only in certain cancers, such as melanoma

Glucagon-like peptide1 (GLP1): A gut hormone of potential interest in the treatment of diabetes

The role of nuclear factor-erythroid 2 related factor 2 (Nrf-2) in the protection against lung injury